Longitudinal assessment of neuropathy in type 1 diabetes using novel ophthalmic markers (LANDMark): Study design and baseline characteristics

Diabetes Research and Clinical Practice

Volumn 104, Issue 2, 2014, Pages 248-256

  Pritchard, Nicola ^a   Edwards, Katie ^a   Dehghani, Cirous ^a   Fadavi, Hassan ^b   Jeziorska, Maria ^b   Marshall, Andrew ^b   Petropoulos, Ioannis N ^b   Ponirakis, Georgios ^b   Russell, Anthony W ^c   Sampson, Geoff P ^a   Shahidi, Ayda M ^a   Srinivasan, Sangeetha ^a   Tavakoli, Mitra ^b   Vagenas, Dimitrios ^a   Malik, Rayaz A ^b   Efron, Nathan ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Corneal confocal microscopy; Diabetic neuropathy; LANDMark study; Longitudinal trial; Non contact corneal aesthesiometry

Indexed keywords

CORNEAL CONFOCAL MICROSCOPY; DIABETIC NEUROPATHY; LANDMARK STUDY; LONGITUDINAL TRIAL; NON-CONTACT CORNEAL AESTHESIOMETRY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CORNEA; CORNEAL DISEASES; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; NERVE FIBERS; PROSPECTIVE STUDIES; SENSATION; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA SENSIBILITY; CORNEAL NERVE FIBER LENGTH; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; NON CONTACT CORNEAL AESTHESIOMETRY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; STUDY DESIGN; UNITED KINGDOM; VISUAL NERVOUS SYSTEM; VISUAL SYSTEM EXAMINATION;

EID: 84898820569     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.02.011     Document Type: Article

References (40)

1. Abbott C.A., Vileikyte L., Williamson S., Carrington A.L., Boulton A.J. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diab Care 1998, 21:1071-1075.
2. Dyck P.J., Davies J.L., Wilson D.M., Service F.J., Melton L.J., O'Brien P.C. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diab Care 1999, 22:1479-1486.
3. Tesfaye S., Boulton A.J., Dyck P.J., Freeman R., Horowitz M., Kempler P., et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diab Care 2010, 33:2285-2293.
4. Callaghan B.C., Little A.A., Feldman E.L., Hughes R.A. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev 2013, CD007543.
5. Calles-Escandón J., Lovato L.C., Simons-Morton D.G., Kendall D.M., Pop-Busui R., Cohen R.M., et al. Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diab Care 2012, 33:721-727.
6. Malik R., Veves A., Tesfaye S., Smith G., Cameron N., Zochodne D., et al. Small fiber neuropathy: role in the diagnosis of diabetic sensorimotor polyneuropathy. Diab Metab Res Rev 2011, 27:678-684.
7. Ziegler D., Low P.A., Litchy W.J., Boulton A.J., Vinik A.I., Freeman R., et al. Efficacy and safety of antioxidant treatment with a-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diab Care 2011, 34:2054-2060.
8. Dyck P.J., Overland C.J., Low P.A., Litchy W.J., Davies J.L., Dyck P.J., et al. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial. Muscle Nerve 2010, 42:157-164.
9. Malik R.A., Veves A., Walker D., Siddique I., Lye R.H., Schady W., et al. Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol 2001, 101:367-374.
10. Malik R.A., Tesfaye S., Newrick P.G., Walker D., Rajbhandari S.M., Sharma A.K., et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 2005, 48:578-585.
11. Sumner C.J., Sheth S., Griffin J.W., Cornblath D.R., Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003, 60:108-111.
12. Oliveira-Soto L., Efron N. Morphology of corneal nerves using confocal microscopy. Cornea 2001, 20:374-384.
13. Hossain P., Sachdev A., Malik R.A. Early detection of diabetic peripheral neuropathy with corneal confocal microscopy. Lancet 2005, 366:1340-1343.
14. Tavakoli M., Kallinikos P.A., Efron N., Boulton A.J.M., Malik R.A. Corneal sensitivity is reduced and relates to the severity of neuropathy in patients with diabetes. Diab Care 2007, 30:1895-1897.
15. Quattrini C., Tavakoli M., Jeziorska M., Kallinikos P., Tesfaye S., Finnigan J., et al. Surrogate markers of small fibre damage in human diabetic neuropathy. Diabetes 2007, 56:2148-2154.
16. Cavanagh P., Attinger C., Abbas Z., Bal A., Rojas N., Xu Z.R. Cost of treating diabetic foot ulcers in five different countries. Diab Metab Res Rev 2012, 28(Suppl. 1):107-111.
17. Tavakoli M., Quattrini C., Abbott C., Kallinikos P., Marshall A., Finnigan J., et al. Corneal confocal microscopy: an in vivo, non-invasive test to diagnose and stratify the severity of human diabetic neuropathy. Diab Care 2012, 33:1792-1797.
18. Pritchard N., Edwards K., Vagenas D., Shahidi A.M., Sampson G.P., Russell A.W., et al. Corneal sensitivity as an ophthalmic marker of diabetic neuropathy. Optom Vis Sci 2010, 87:1003-1008.
19. Albers J.W., Herman W.H., Pop-Busui R., Feldman E.L., Martin C.L., Cleary P.A., et al. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diab Care 2010, 33:1090-1096.
20. Partanen J., Niskanen L., Lehtinen J., Mervaala E., Siitonen O., Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995, 333:89-94.
21. Dyck P.J., Norell J.E., Tritschler H., Schuette K., Samigullin R., Ziegler D., et al. Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity. Diab Care 2007, 30:2619-2625.
22. Meijer J.W., Bosma E., Lefrandt J.D., Links T.P., Smit A.J., Stewart R.E., et al. Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores. Diab Care 2003, 26:697-701.
23. Young M.J., Boulton A.J.M., Macleod A.F., Williams D.R.R., Sonksen P.H. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993, 36:150-154.
24. Dabbah M.A., Graham J., Petropoulos I.N., Tavakoli M., Malik R.A. Automatic analysis of diabetic peripheral neuropathy using multi-scale quantitative morphology of nerve fibres in corneal confocal microscopy imaging. Med Image Anal 2011, 15:738-747.
25. Murphy P.J., Patel S., Marshall J. A new non-contact corneal aesthesiometer (NCCA). Ophthalmic Physiol Opt 1996, 16:101-107.
26. Papanas N., Boulton A.J., Malik R.A., Manes C., Schnell O., Spallone V., et al. A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy. Diabet Med 2013, 30:525-534.
27. Wilkinson C.P., Ferris F.L., Klein R.E., Lee P.P., Agardh C.D., Davis M., et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003, 110:1677-1682.
28. Anon Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diab Care 2003, 22:99-111.
29. Lorbeer R., Empen K., Dörr M., Arndt M., Schipf S., Nauck M., et al. Association between glycosylated haemoglobin A(1c) and endothelial function in an adult non-diabetic population. Atherosclerosis 2011, 217:358-363.
30. Niederer R.L., Perumal D., Sherwin T., McGhee C.N. Laser scanning in vivo confocal microscopy reveals reduced innervation and reduction in cell density in all layers of the keratoconic cornea. Invest Ophthalmol Vis Sci 2008, 49:2964-2970.
31. Patel D.V., McGhee C.N.J. Mapping of the normal human corneal sub-basal nerve plexus by in vivo laser scanning confocal microscopy. Invest Ophthalmol Vis Sci 2005, 46:4485-4488.
32. Patel D.V., Tavakoli M., Craig J.P., Efron N., McGhee C.N. Corneal sensitivity and slit scanning in vivo confocal microscopy of the subbasal nerve plexus of the normal central and peripheral human cornea. Cornea 2009, 28:735-740.
33. Ahmed A., Bril V., Orszag A., Paulson J., Yeung E., Ngo M., et al. Detection of diabetic sensorimotor polyneuropathy by corneal confocal microscopy in type 1 diabetes: a concurrent validity study. Diab Care 2012, 35:821-828.
34. Hertz P., Bril V., Orszag A., Ahmed A., Ng E., New P., et al. Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy. Diabet Med 2011, 28:1253-1260.
35. Ishibashi F., Okino M., Ishibashi M., Kawasaki A., Endo N., Kosaka A., et al. Corneal nerve fiber pathology in Japanese type 1 diabetic patients and its correlation with antecedent glycemic control and blood pressure. J Diabet Invest 2012, 3:191-198.
36. Tavakoli M., Mitu-Pretorian M., Petropoulos I.N., Fadavi H., Asghar O., Alam U., et al. Corneal confocal microscopy detects early nerve regeneration in diabetic neuropathy after simultaneous pancreas and kidney transplantation. Diabetes 2013, 62:254-260.
37. Messmer E.M., Schmid-Tannwald C., Zapp D., Kampik A. In vivo confocal microscopy of corneal small fiber damage in diabetes mellitus. Graefes Arch Clin Exp Ophthalmol 2010, 248:1307-1312.
38. Cousen P., Cackett P., Bennett H., Swa K., Dhillon B. Tear production and corneal sensitivity in diabetes. J Diab Complications 2007, 21:371-373.
39. Mehra S., Tavakoli M., Kallinikos P.A., Efron N., Boulton A.J., Augustine T., et al. Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diab Care 2007, 30:2608-2612.
40. Murphy P.J., Patel S., Kong N., Ryder R.E.J., Marshall J. Noninvasive assessment of corneal sensitivity in young and elderly diabetic and nondiabetic subjects. Invest Ophthalmol Vis Sci 2004, 45:1737-1742.